Gosset provides a decision intelligence platform specifically for the life sciences industry, delivering competitive insights derived from clinical evidence. The platform uses purpose-built AI agents to continuously analyze multi-asset landscapes, tracking competitor progress and automating benchmarking for pipeline strategy. Users access human-verified data and AI-generated analyses via dashboards, natural language queries, or API integration to support investment and due diligence decisions.
Funding
Funding not disclosed
Founders
Product
Problem
Biotechnology firms and investment funds face challenges in accurately predicting clinical trial success due to the complexity and volume of data required for comprehensive analysis. Sifting through numerous research papers, conference posters, and investor decks to find relevant safety, efficacy, and trial design information is time-consuming and prone to errors. This lack of readily available, verified data hinders informed decision-making in portfolio management and investment strategies.
Solution
Gosset is a biotech intelligence platform that leverages AI and verified clinical trial results data to provide accurate predictions of trial success. The platform consolidates safety and efficacy results data from every time point of every trial for every drug, along with structured trial design and eligibility criteria. This comprehensive dataset enables users to conduct head-to-head drug comparisons and nuanced competitive landscape analyses. Gosset streamlines the decision-making process by offering interactive graphs, filterable tables, and data available via dashboard, spreadsheet, or API.
Target Audience
The primary target audience includes biotechnology investors, corporate development teams, and biotech consultants who require comprehensive clinical trial data for informed capital allocation and strategic decision-making.
Features
- Head-to-head drug comparison tables for every disease, incorporating safety and efficacy results data.
- Structured trial design data and eligibility criteria for every trial, facilitating easy filtering and analysis.
- Aggregation of results data from research papers, conference posters, investor decks, and press releases, verified by human experts.
- Interactive dashboards with graphs and filterable tables for quick insights.
- Data accessibility via comprehensive spreadsheets and API for custom analysis and integration.
- Identification of all drugs in active development for a specific disease, including placebo performance data.
- Identification of standard-of-care drugs with corresponding safety and efficacy data.